Page last updated: 2024-11-06

triethylenemelamine and Burkitt Lymphoma

triethylenemelamine has been researched along with Burkitt Lymphoma in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malacarne, P1
Castaldi, G1
Halama, J1

Reviews

1 review available for triethylenemelamine and Burkitt Lymphoma

ArticleYear
[Kaposi's sarcoma in children].
    Monatsschrift fur Kinderheilkunde, 1972, Volume: 120, Issue:2

    Topics: Age Factors; Biopsy; Burkitt Lymphoma; Child; Cyclophosphamide; Dactinomycin; Diagnosis, Differentia

1972

Other Studies

1 other study available for triethylenemelamine and Burkitt Lymphoma

ArticleYear
["Starry sky' aspect of the thymus gland following the use of lympholytic drugs].
    Haematologica, 1972, Volume: 57, Issue:12

    Topics: Animals; Burkitt Lymphoma; Mice; Niacinamide; Phagocytosis; Prednisolone; Thymus Gland; Triethylenem

1972